{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"title":"2yr overall survival"},{"categories":[{"measurements":[{"groupId":"OG000","value":"18"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"title":"3yr overall survival"},{"categories":[{"measurements":[{"groupId":"OG000","value":"13"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"title":"2yr lung-metastasis progression free survival"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"title":"3yr lung-metastasis progression free survival"},{"categories":[{"measurements":[{"groupId":"OG000","value":"8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"title":"Pulmonary relapse"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"title":"Pulmonary relapse - after primary therapy"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"title":"Pulmonary relapse - after relapse/progression"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"title":"Deceased from progressive disease"}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Serial CT scans of the chest were examined to determine lung-metastasis free survival","groups":[{"description":"Patients undergo cardiac-sparing whole lung intensity-modulated radiation therapy (IMRT).","id":"OG000","title":"Treatment (IMRT)"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Overall survival and incidence rates of additional relevant clinical data","reportingStatus":"POSTED","timeFrame":"From date of enrollment until the date of first documented progression, relapse or date of death from any cause up to an average of 3 years.","title":"Short-term Efficacy (Lung-metastases Free Survival, Overall Survival, Pulmonary Relapse, Deceased From Progressive Disease)","type":"PRIMARY","unitOfMeasure":"Participants"}